US Stock MarketDetailed Quotes

Allarity Therapeutics (ALLR)

Watchlist
  • 1.680
  • +0.130+8.39%
Close May 11 16:00 ET
  • 1.661
  • -0.020-1.16%
Post 19:51 ET
26.58MMarket Cap-2.15P/E (TTM)

Allarity Therapeutics (ALLR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
320K
320K
0
0
0
0
0
0
0
0
Operating revenue
--320K
--320K
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.30%12.93M
-55.75%3.24M
-3.52%2.52M
22.60%4.13M
-28.40%3.04M
2.39%17.54M
49.97%7.32M
-41.03%2.61M
-18.89%3.37M
15.59%4.24M
Selling and administrative expenses
-44.73%6.32M
-71.41%1.56M
-17.24%1.32M
-21.66%1.81M
-21.11%1.63M
14.12%11.44M
142.46%5.47M
-35.88%1.59M
-24.19%2.31M
-7.63%2.07M
-General and administrative expense
-44.73%6.32M
-71.41%1.56M
-17.24%1.32M
-21.66%1.81M
-21.11%1.63M
14.12%11.44M
142.46%5.47M
-35.88%1.59M
-24.19%2.31M
-7.63%2.07M
Research and development costs
8.28%6.6M
-9.37%1.67M
17.83%1.2M
119.38%2.32M
-35.35%1.4M
-14.18%6.1M
-29.58%1.85M
-47.59%1.02M
-4.25%1.06M
52.07%2.17M
Operating profit
28.13%-12.61M
60.12%-2.92M
3.52%-2.52M
-22.60%-4.13M
28.40%-3.04M
-2.39%-17.54M
-49.97%-7.32M
41.03%-2.61M
18.89%-3.37M
-15.59%-4.24M
Net non-operating interest income expense
613.33%616K
-33.33%96K
-38.39%130K
160.32%225K
261.76%165K
74.79%-120K
163.44%144K
1,059.09%211K
-168.35%-373K
-15.91%-102K
Non-operating interest income
50.28%801K
-29.22%155K
-28.35%187K
347.17%237K
--222K
2,322.73%533K
7,200.00%219K
2,075.00%261K
1,666.67%53K
--0
Non-operating interest expense
-71.67%185K
-21.33%59K
14.00%57K
-97.18%12K
-44.12%57K
31.12%653K
-67.39%75K
47.06%50K
200.00%426K
10.87%102K
Other net income (expense)
110.47%758K
-96.79%-551K
95.63%-418K
-24.92%1.59M
-71.92%139K
-225.07%-7.24M
-108.08%-280K
-956,900.00%-9.57M
10.44%2.12M
22.52%495K
Gain on sale of security
-69.25%758K
-96.79%-551K
-409.63%-418K
-24.92%1.59M
-71.92%139K
-61.35%2.47M
-106.90%-280K
13,400.00%135K
10.44%2.12M
22.52%495K
Special income (charges)
--0
--0
--0
----
----
---9.7M
--0
---9.7M
----
----
-Less:Impairment of capital assets
--0
--0
--0
----
----
--9.7M
--0
--9.7M
----
----
Income before tax
54.89%-11.23M
54.74%-3.37M
76.55%-2.81M
-42.42%-2.32M
28.98%-2.73M
-110.66%-24.9M
-354.73%-7.45M
-169.10%-11.97M
31.55%-1.63M
-14.77%-3.85M
Income tax
0
0
0
0
0
-559.04%-381K
0
-377K
0
-4K
Net income
54.19%-11.23M
54.74%-3.37M
75.79%-2.81M
-42.42%-2.32M
28.91%-2.73M
-105.99%-24.52M
-332.81%-7.45M
-160.63%-11.59M
31.55%-1.63M
-14.65%-3.84M
Net income continuous Operations
54.19%-11.23M
54.74%-3.37M
75.79%-2.81M
-42.42%-2.32M
28.91%-2.73M
-105.99%-24.52M
-332.81%-7.45M
-160.63%-11.59M
31.55%-1.63M
-14.65%-3.84M
Minority interest income
Net income attributable to the parent company
54.19%-11.23M
54.74%-3.37M
75.79%-2.81M
-42.42%-2.32M
28.91%-2.73M
-105.99%-24.52M
-332.81%-7.45M
-160.63%-11.59M
31.55%-1.63M
-14.65%-3.84M
Preferred stock dividends
-92.50%639K
-222K
-49.14%562K
-99.04%71K
5,600.00%228K
Other preferred stock dividends
0
0
0
0
-31K
-191K
Net income attributable to common stockholders
55.35%-11.23M
54.74%-3.37M
76.91%-2.81M
-39.01%-2.32M
29.59%-2.73M
-23.21%-25.15M
-332.81%-7.45M
-118.88%-12.15M
82.95%-1.67M
-15.61%-3.88M
Basic earnings per share
95.02%-0.78
79.42%-0.21
97.54%-0.19
95.51%-0.15
99.96%-0.25
99.74%-15.65
99.42%-1.0206
99.43%-7.71
99.97%-3.34
99.03%-664.16
Diluted earnings per share
95.02%-0.78
79.42%-0.21
97.54%-0.19
95.51%-0.15
99.96%-0.25
99.74%-15.65
99.42%-1.0206
99.43%-7.71
99.97%-3.34
99.03%-664.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 320K320K00000000
Operating revenue --320K--320K--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.30%12.93M-55.75%3.24M-3.52%2.52M22.60%4.13M-28.40%3.04M2.39%17.54M49.97%7.32M-41.03%2.61M-18.89%3.37M15.59%4.24M
Selling and administrative expenses -44.73%6.32M-71.41%1.56M-17.24%1.32M-21.66%1.81M-21.11%1.63M14.12%11.44M142.46%5.47M-35.88%1.59M-24.19%2.31M-7.63%2.07M
-General and administrative expense -44.73%6.32M-71.41%1.56M-17.24%1.32M-21.66%1.81M-21.11%1.63M14.12%11.44M142.46%5.47M-35.88%1.59M-24.19%2.31M-7.63%2.07M
Research and development costs 8.28%6.6M-9.37%1.67M17.83%1.2M119.38%2.32M-35.35%1.4M-14.18%6.1M-29.58%1.85M-47.59%1.02M-4.25%1.06M52.07%2.17M
Operating profit 28.13%-12.61M60.12%-2.92M3.52%-2.52M-22.60%-4.13M28.40%-3.04M-2.39%-17.54M-49.97%-7.32M41.03%-2.61M18.89%-3.37M-15.59%-4.24M
Net non-operating interest income expense 613.33%616K-33.33%96K-38.39%130K160.32%225K261.76%165K74.79%-120K163.44%144K1,059.09%211K-168.35%-373K-15.91%-102K
Non-operating interest income 50.28%801K-29.22%155K-28.35%187K347.17%237K--222K2,322.73%533K7,200.00%219K2,075.00%261K1,666.67%53K--0
Non-operating interest expense -71.67%185K-21.33%59K14.00%57K-97.18%12K-44.12%57K31.12%653K-67.39%75K47.06%50K200.00%426K10.87%102K
Other net income (expense) 110.47%758K-96.79%-551K95.63%-418K-24.92%1.59M-71.92%139K-225.07%-7.24M-108.08%-280K-956,900.00%-9.57M10.44%2.12M22.52%495K
Gain on sale of security -69.25%758K-96.79%-551K-409.63%-418K-24.92%1.59M-71.92%139K-61.35%2.47M-106.90%-280K13,400.00%135K10.44%2.12M22.52%495K
Special income (charges) --0--0--0-----------9.7M--0---9.7M--------
-Less:Impairment of capital assets --0--0--0----------9.7M--0--9.7M--------
Income before tax 54.89%-11.23M54.74%-3.37M76.55%-2.81M-42.42%-2.32M28.98%-2.73M-110.66%-24.9M-354.73%-7.45M-169.10%-11.97M31.55%-1.63M-14.77%-3.85M
Income tax 00000-559.04%-381K0-377K0-4K
Net income 54.19%-11.23M54.74%-3.37M75.79%-2.81M-42.42%-2.32M28.91%-2.73M-105.99%-24.52M-332.81%-7.45M-160.63%-11.59M31.55%-1.63M-14.65%-3.84M
Net income continuous Operations 54.19%-11.23M54.74%-3.37M75.79%-2.81M-42.42%-2.32M28.91%-2.73M-105.99%-24.52M-332.81%-7.45M-160.63%-11.59M31.55%-1.63M-14.65%-3.84M
Minority interest income
Net income attributable to the parent company 54.19%-11.23M54.74%-3.37M75.79%-2.81M-42.42%-2.32M28.91%-2.73M-105.99%-24.52M-332.81%-7.45M-160.63%-11.59M31.55%-1.63M-14.65%-3.84M
Preferred stock dividends -92.50%639K-222K-49.14%562K-99.04%71K5,600.00%228K
Other preferred stock dividends 0000-31K-191K
Net income attributable to common stockholders 55.35%-11.23M54.74%-3.37M76.91%-2.81M-39.01%-2.32M29.59%-2.73M-23.21%-25.15M-332.81%-7.45M-118.88%-12.15M82.95%-1.67M-15.61%-3.88M
Basic earnings per share 95.02%-0.7879.42%-0.2197.54%-0.1995.51%-0.1599.96%-0.2599.74%-15.6599.42%-1.020699.43%-7.7199.97%-3.3499.03%-664.16
Diluted earnings per share 95.02%-0.7879.42%-0.2197.54%-0.1995.51%-0.1599.96%-0.2599.74%-15.6599.42%-1.020699.43%-7.7199.97%-3.3499.03%-664.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More